Selman Ali

653 total citations
23 papers, 534 citations indexed

About

Selman Ali is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Selman Ali has authored 23 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Selman Ali's work include Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (5 papers). Selman Ali is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (5 papers). Selman Ali collaborates with scholars based in United Kingdom, Iran and Tanzania. Selman Ali's co-authors include Robert C. Rees, Dennis D. Taub, Shahzad I. Mian, Stéphanie McArdle, Geng Li, C. S. McLean, Murrium Ahmad, Claire Entwisle, Quentin S. Hanley and Peter T. Loudon and has published in prestigious journals such as The Journal of Immunology, International Journal of Cancer and Vaccine.

In The Last Decade

Selman Ali

22 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Selman Ali United Kingdom 12 244 238 198 67 60 23 534
Silvia Valensin Italy 13 113 0.5× 225 0.9× 346 1.7× 51 0.8× 30 0.5× 22 659
Michéle Brillard‐Bourdet France 16 119 0.5× 138 0.6× 220 1.1× 76 1.1× 88 1.5× 24 666
Natalia Sigal United States 12 170 0.7× 759 3.2× 526 2.7× 64 1.0× 27 0.5× 22 1.2k
Simon Hör Germany 9 306 1.3× 546 2.3× 169 0.9× 79 1.2× 12 0.2× 10 846
Tsion E. Abraham Netherlands 10 216 0.9× 193 0.8× 417 2.1× 68 1.0× 24 0.4× 15 658
Hema Srinath United States 6 165 0.7× 329 1.4× 252 1.3× 33 0.5× 17 0.3× 6 551
Ruth Swofford United States 6 233 1.0× 523 2.2× 272 1.4× 29 0.4× 42 0.7× 8 868
Suvana S. Lam United States 12 246 1.0× 315 1.3× 787 4.0× 75 1.1× 24 0.4× 12 1.1k
Emil H. Palacios United States 7 224 0.9× 659 2.8× 319 1.6× 43 0.6× 42 0.7× 8 994
Annette H. Andersen Denmark 7 76 0.3× 203 0.9× 646 3.3× 51 0.8× 58 1.0× 7 877

Countries citing papers authored by Selman Ali

Since Specialization
Citations

This map shows the geographic impact of Selman Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selman Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selman Ali more than expected).

Fields of papers citing papers by Selman Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Selman Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selman Ali. The network helps show where Selman Ali may publish in the future.

Co-authorship network of co-authors of Selman Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Selman Ali. A scholar is included among the top collaborators of Selman Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Selman Ali. Selman Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ali, Selman, et al.. (2022). Paradoxical immune response in leishmaniasis: The role of toll‐like receptors in disease progression. Parasite Immunology. 44(4-5). e12910–e12910. 8 indexed citations
2.
Rezvan, Hossein, et al.. (2022). Inhibitory Effects of Leishmania Mexicana infection on MHC-I Expression in Bone Marrow Derived Dendritic Cells. Iranian Journal of Parasitology. 17(4). 562–572.
4.
Murray, Kathryn, Yuan‐Cheng Cao, Selman Ali, & Quentin S. Hanley. (2010). Lanthanide doped silica nanoparticles applied to multiplexed immunoassays. The Analyst. 135(8). 2132–2132. 25 indexed citations
5.
Zhou, Yanzhou, et al.. (2009). Confocal detection of planar homogeneous and heterogeneous immunosorbent assays. Journal of Biomedical Optics. 14(6). 64022–64022. 3 indexed citations
6.
Ahmad, Murrium, Robert C. Rees, Stéphanie McArdle, et al.. (2005). Regulation of CTL responses to MHC‐restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC–mGM‐CSF. International Journal of Cancer. 115(6). 951–959. 7 indexed citations
7.
Assudani, Deepak, Murrium Ahmad, Geng Li, Robert C. Rees, & Selman Ali. (2005). Immunotherapeutic potential of DISC-HSV and OX40L in cancer. Cancer Immunology Immunotherapy. 55(1). 104–111. 13 indexed citations
8.
Ali, Selman, et al.. (2004). Trafficking of tumor peptide‐specific cytotoxic T lymphocytes into the tumor microcirculation. International Journal of Cancer. 110(2). 239–244. 13 indexed citations
9.
Ali, Selman, Murrium Ahmad, C. S. McLean, et al.. (2004). Anti-tumour therapeutic efficacy of OX40L in murine tumour model. Vaccine. 22(27-28). 3585–3594. 43 indexed citations
10.
Rojas, José M., Stéphanie McArdle, Matthew Bell, et al.. (2004). Peptide immunisation of HLA-DR?transgenic mice permits the identification of a novel HLA-DR?1*0101? and HLA-DR?1*0401?restricted epitope from p53. Cancer Immunology Immunotherapy. 54(3). 243–253. 21 indexed citations
12.
Parkinson, Richard, Shahzad I. Mian, M.C. Bishop, et al.. (2003). Disabled infectious single cycle herpes simplex virus (DISC‐HSV) is a candidate vector system for gene delivery/expression of GM‐CSF in human prostate cancer therapy. The Prostate. 56(1). 65–73. 7 indexed citations
13.
McArdle, Stéphanie, Selman Ali, Geng Li, Shahzad I. Mian, & Robert C. Rees. (2003). Phenotypic and Functional Differences of Dendritic Cells Generated Under Different In Vitro Conditions. Humana Press eBooks. 81. 359–376. 4 indexed citations
15.
Rees, Robert C., Stéphanie McArdle, Shahzad I. Mian, et al.. (2002). Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer.. PubMed. 4(1). 49–53. 15 indexed citations
16.
Todryk, Stephen, et al.. (1999). Disabled Infectious Single-Cycle Herpes Simplex Virus as an Oncolytic Vector for Immunotherapy of Colorectal Cancer. Human Gene Therapy. 10(17). 2757–2768. 35 indexed citations
17.
Rees, Robert C., Craig Murdoch, John F. Marshall, et al.. (1999). Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: Subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials. Clinical & Experimental Metastasis. 17(5). 389–396. 34 indexed citations
18.
Li, Geng, Selman Ali, John F. Marshall, et al.. (1998). Fibronectin is chemotactic for CT 26 colon carcinoma cells: sub-lines selected for increased chemotaxis to fibronectin display decreased tumorigenicity and lung colonization. Clinical & Experimental Metastasis. 16(8). 683–691. 14 indexed citations
19.
Ali, Selman, et al.. (1997). Chemokines induce migrational responses in human breast carcinoma cell lines. International Journal of Cancer. 71(2). 257–266. 189 indexed citations
20.
Zubair, Abba C., Selman Ali, Robert C. Rees, et al.. (1996). Analysis of the Colonization of Unirradiated and Irradiated SCID Mice by Human Lymphoma and Non-malignant Lymphoid Cells. Leukemia & lymphoma. 22(5-6). 463–471. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026